0 CHECKOUT

Food Allergy - Pipeline Review, H2 2015

  • ID: 3502768
  • October 2015
  • 49 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • AnaptysBio, Inc.
  • Biomay AG
  • DBV Technologies S.A.
  • Sanofi
  • Selecta Biosciences, Inc.
  • Swecure AB
  • MORE

Food Allergy - Pipeline Review, H2 2015

Summary

The report ‘Food Allergy - Pipeline Review, H2 2015’, provides an overview of the Food Allergy’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Food Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Food Allergy and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AnaptysBio, Inc.
  • Biomay AG
  • DBV Technologies S.A.
  • Sanofi
  • Selecta Biosciences, Inc.
  • Swecure AB
  • MORE

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Food Allergy Overview

Therapeutics Development

Pipeline Products for Food Allergy - Overview

Pipeline Products for Food Allergy - Comparative Analysis

Food Allergy - Therapeutics under Development by Companies

Food Allergy - Therapeutics under Investigation by Universities/Institutes

Food Allergy - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Food Allergy - Products under Development by Companies

Food Allergy - Products under Investigation by Universities/Institutes

Food Allergy - Companies Involved in Therapeutics Development

AnaptysBio, Inc.

Biomay AG

DBV Technologies S.A.

Immunomic Therapeutics, Inc.

Sanofi

Selecta Biosciences, Inc.

Swecure AB

Food Allergy - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

Allergen for Egg Allergy - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Allergen for Milk Allergy - Drug Profile

Product Description

Mechanism of Action

R&D Progress

ANB-020 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Drug 1 for Food Allergy - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Drug 2 for Food Allergy - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Epsi-Gam - Drug Profile

Product Description

Mechanism of Action

R&D Progress

fish hypoallergenic vaccine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

food allergy vaccine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Pru p 3 Allergen for Peach Allergy - Drug Profile

Product Description

Mechanism of Action

R&D Progress

SWE-01 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

TN-LAMP-vax - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Vaccine for Food Allergy - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Vaccines for Peach Allergy - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Food Allergy - Recent Pipeline Updates

Food Allergy - Dormant Projects

Food Allergy - Dormant Projects

Food Allergy - Product Development Milestones

Featured News & Press Releases

Jan 10, 2014: AnaptysBio Announces Development of Novel anti-IL33 Therapeutic Antibody

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Food Allergy, H2 2015

Number of Products under Development for Food Allergy - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Investigation by Universities/Institutes, H2 2015

Food Allergy - Pipeline by AnaptysBio, Inc., H2 2015

Food Allergy - Pipeline by Biomay AG, H2 2015

Food Allergy - Pipeline by DBV Technologies S.A., H2 2015

Food Allergy - Pipeline by Immunomic Therapeutics, Inc., H2 2015

Food Allergy - Pipeline by Sanofi, H2 2015

Food Allergy - Pipeline by Selecta Biosciences, Inc., H2 2015

Food Allergy - Pipeline by Swecure AB, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Food Allergy Therapeutics - Recent Pipeline Updates, H2 2015

Food Allergy - Dormant Projects, H2 2015

List of Figures

Number of Products under Development for Food Allergy, H2 2015

Number of Products under Development for Food Allergy - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Top 10 Routes of Administration, H2 2015

Number of Products by Stage and Top 10 Routes of Administration, H2 2015

Number of Products by Top 10 Molecule Types, H2 2015

Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

AnaptysBio, Inc.
Biomay AG
DBV Technologies S.A.
Immunomic Therapeutics, Inc.
Sanofi
Selecta Biosciences, Inc.
Swecure AB

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Merck & Co., Inc.
  • Celgene Corporation
  • GlaxoSmithKline PLC
  • Genentech, Inc.
  • Johnson & Johnson Services, Inc.
  • ViiV Healthcare